Cargando…
The "promoting" activity of methyl methanesulphonate in rat bladder carcinogenesis.
The carcinogenic activity of the alkylating agent methyl methanesulphonate (MMS) was investigated in the F344 rat bladder, both untreated and pretreated with a single threshold dose of N-methyl-N-nitrosourea (MNU). On its own, 6 doses of 2.5 mg MMS produced a 7% incidence of bladder cancer. After a...
Autores principales: | Tudor, R. J., Severs, N. J., Hicks, R. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1984
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976922/ https://www.ncbi.nlm.nih.gov/pubmed/6743515 |
Ejemplares similares
-
The induction of urothelial hyperplasia by methyl methanesulphonate and ethyl methanesulphonate.
por: Tudor, R. J., et al.
Publicado: (1983) -
Induction of tumours in intact and partially hepatectomized rats with ethyl methanesulphonate.
por: Craddock, V. M., et al.
Publicado: (1976) -
Induction of bladder cancer in rats by fractionated intravesicular doses of N-methyl-N-nitrosourea.
por: Severs, N. J., et al.
Publicado: (1982) -
Protocol for ethyl methanesulphonate (EMS) mutagenesis application in rice
por: Unan, Rasim, et al.
Publicado: (2022) -
Resistance to 4-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in human myeloid leukaemia.
por: Skinner, W. L., et al.
Publicado: (1990)